![Rune Skeie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rune Skeie currently works at BerGenBio Ltd., as Director from 2018.
Mr. Skeie also formerly worked at Ernst & Young AS, as Executive Director, REMA 1000 AS, as Chief Financial Officer, and Oncoinvent ASA, as Chief Executive & Financial Officer in 2021.
| Companies | Position | Start |
|---|---|---|
BerGenBio Ltd.
 BerGenBio Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative drugs for targeting cancers | Director/Board Member | 05/03/2018 |
| Companies | Position | End |
|---|---|---|
Ernst & Young AS
 Ernst & Young AS Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Director/Board Member | - |
REMA 1000 AS
 REMA 1000 AS Food RetailRetail Trade Offers a chain of supermarket | Director of Finance/CFO | - |
| ONCOINVENT ASA | Chief Executive Officer | 08/09/2021 |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Ernst & Young AS
Ernst & Young AS Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
REMA 1000 AS
REMA 1000 AS Food RetailRetail Trade Offers a chain of supermarket | Retail Trade |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
BerGenBio Ltd.
BerGenBio Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative drugs for targeting cancers | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
